Literature DB >> 2245764

[Hyperprolactinemia in malignant lymphomas].

N Grobe1, H Rühle, G Eckelmann.   

Abstract

Serum prolactin levels at the time of confirmed diagnosis and of remission were determined prospectively in 36 patients (22 males, 14 females; mean age 54.2 [18-77] years), 12 with Hodgkin and 24 with non-Hodgkin lymphoma. Basal prolactin levels were elevated to a mean of 1900 (720- greater than 4000) mU/l in 12 patients. Eight of these had extranodal manifestations of lymphoma. At the time of remission the elevated prolactin levels had returned to normal in six patients. The cortisol concentrations of the 36 patients did not correlate with the prolactin levels so that stress-induced increase in secretion seems unlikely. These results point to prolactin possibly playing a role as a nonspecific tumour marker. In addition, lymphomas should be included in the differential diagnosis of hyperprolactinaemia.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2245764     DOI: 10.1055/s-2008-1065232

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  2 in total

1.  Non-Hodgkin lymphoma with panhypopituitarism, hyperprolactinaemia and sixth nerve palsy.

Authors:  J A Shaw; F M Strachan; H A Sawers; J S Bevan
Journal:  J R Soc Med       Date:  1997-05       Impact factor: 5.344

2.  Pineal Diffuse Large B-Cell Lymphoma Concomitant With Pituitary Prolactinoma: Possible Correlation Between 2 Distinguished Pathologies: A Case Report.

Authors:  Yeong-Jin Kim; Hee Kyung Kim; Deok-Hwan Yang; Shin Jung; Myung-Giun Noh; Jae-Hyuk Lee; Kyung-Hwa Lee; Kyung-Sub Moon
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.